80 related articles for article (PubMed ID: 14691454)
21. Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells.
Willipinski-Stapelfeldt B; Riethdorf S; Assmann V; Woelfle U; Rau T; Sauter G; Heukeshoven J; Pantel K
Clin Cancer Res; 2005 Nov; 11(22):8006-14. PubMed ID: 16299229
[TBL] [Abstract][Full Text] [Related]
22. In vitro exposure to paclitaxel modulates integrin expression by human T lymphocytes and inhibits T cell adhesion to breast carcinoma cells.
Bhan V; Mader JS; Hoskin DW
Oncol Rep; 2004 Apr; 11(4):893-7. PubMed ID: 15010891
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.
Gery S; Tanosaki S; Bose S; Bose N; Vadgama J; Koeffler HP
Clin Cancer Res; 2005 May; 11(9):3184-90. PubMed ID: 15867211
[TBL] [Abstract][Full Text] [Related]
24. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma.
Sathyanarayana UG; Padar A; Huang CX; Suzuki M; Shigematsu H; Bekele BN; Gazdar AF
Clin Cancer Res; 2003 Dec; 9(17):6389-94. PubMed ID: 14695139
[TBL] [Abstract][Full Text] [Related]
25. Increased expression of geminin stimulates the growth of mammary epithelial cells and is a frequent event in human tumors.
Montanari M; Boninsegna A; Faraglia B; Coco C; Giordano A; Cittadini A; Sgambato A
J Cell Physiol; 2005 Jan; 202(1):215-22. PubMed ID: 15389519
[TBL] [Abstract][Full Text] [Related]
26. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
[TBL] [Abstract][Full Text] [Related]
27. Enhanced immunity to intracerebral breast cancer in mice immunized with a cDNA-based vaccine enriched for immunotherapeutic cells.
Lichtor T; Glick RP; Feldman LA; Osawa G; Hardman J; O- Sullivan I; Cohen EP
J Immunother; 2008 Jan; 31(1):18-27. PubMed ID: 18157008
[TBL] [Abstract][Full Text] [Related]
28. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
[TBL] [Abstract][Full Text] [Related]
29. Expression of the steroid and xenobiotic receptor and its possible target gene, organic anion transporting polypeptide-A, in human breast carcinoma.
Miki Y; Suzuki T; Kitada K; Yabuki N; Shibuya R; Moriya T; Ishida T; Ohuchi N; Blumberg B; Sasano H
Cancer Res; 2006 Jan; 66(1):535-42. PubMed ID: 16397270
[TBL] [Abstract][Full Text] [Related]
30. Autologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitro.
Delirezh N; Moazzeni SM; Shokri F; Shokrgozar MA; Atri M; Kokhaei P
Cell Immunol; 2009; 257(1-2):23-31. PubMed ID: 19306994
[TBL] [Abstract][Full Text] [Related]
31. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
[TBL] [Abstract][Full Text] [Related]
32. Cathepsin-D expression in breast lesion: an immunohistochemical study.
Brujan I; Mărgăritescu C; Simionescu C; Pirici D; Fronie A; Foarfă C; Stepan A; Vrabete M
Rom J Morphol Embryol; 2009; 50(1):31-9. PubMed ID: 19221643
[TBL] [Abstract][Full Text] [Related]
33. Re-evaluation of the prolactin receptor expression in human breast cancer.
Galsgaard ED; Rasmussen BB; Folkesson CG; Rasmussen LM; Berchtold MW; Christensen L; Panina S
J Endocrinol; 2009 Apr; 201(1):115-28. PubMed ID: 19153125
[TBL] [Abstract][Full Text] [Related]
34. Identification of breast cancer-restricted antigens by antibody screening of SKBR3 cDNA library using a preselected patient's serum.
Forti S; Scanlan MJ; Invernizzi A; Castiglioni F; Pupa S; Agresti R; Fontanelli R; Morelli D; Old LJ; Pupa SM; Ménard S
Breast Cancer Res Treat; 2002 Jun; 73(3):245-56. PubMed ID: 12160330
[TBL] [Abstract][Full Text] [Related]
35. Tumor-specific cell-mediated immunity in household contacts of cancer patients.
Byers VS; Levin AS; Hackett AJ; Fudenberg HH
J Clin Invest; 1975 Mar; 55(3):500-13. PubMed ID: 1078827
[TBL] [Abstract][Full Text] [Related]
36. Immunological studies in breast cancer lymphoid populations.
Cervantes C; Exposito G; Moreno L; Garcia ME
Neoplasma; 1979; 26(6):711-9. PubMed ID: 396478
[No Abstract] [Full Text] [Related]
37. Elevated expression and altered processing of fibulin-1 protein in human breast cancer.
Greene LM; Twal WO; Duffy MJ; McDermott EW; Hill AD; O'Higgins NJ; McCann AH; Dervan PA; Argraves WS; Gallagher WM
Br J Cancer; 2003 Mar; 88(6):871-8. PubMed ID: 12644824
[TBL] [Abstract][Full Text] [Related]
38. T (Thomsen-Friedenreich) and Tn epitope location and their spatial relations to adhesion plaques on human breast carcinoma cells: immunogold-silver staining studies at scanning electron microscopic level.
Wang BL; Springer GF; Harwick LC
J Submicrosc Cytol Pathol; 1998 Oct; 30(4):503-9. PubMed ID: 9851058
[TBL] [Abstract][Full Text] [Related]
39. [A mathematical analysis of immunologic indicators in dyshormonal dysplasia and breast cancer].
Zhalgasbaeva GT; Baisheva SA; Ozerova IV; Friazinova TS; Kuralasov AK
Vopr Onkol; 1989; 35(10):1198-203. PubMed ID: 2596063
[TBL] [Abstract][Full Text] [Related]
40. Lymphocyte response to PHA in breast cancer: correlation of predicted prognosis to response to different PHA concentrations.
Whitehead RH; Bolton PM; Newcombe RG; James SL; Hughes LE
Clin Oncol; 1975 Sep; 1(3):191-200. PubMed ID: 1082405
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
